UPDATE : Friday, June 22, 2018
상단여백
Korean pharmaceuticals enter schizophrenia therapy market by Marian Chu 2018-06-22 19:15
GC unveils new dysmenorrhea treatment by Lee Han-soo 2018-06-22 14:15
Shire Korea launches hereditary angioedema therapy Firazyr by Marian Chu 2018-06-21 16:45
Bukwang releases new toenail fungal treatment by Lee Han-soo 2018-06-21 16:29
Roche Diagnostics Korea gets reimbursement for EGFR mutation exam by Marian Chu 2018-06-21 15:39
라인
GSK Korea’s flu vaccine wins nod for use on infants by Marian Chu 2018-06-21 15:38
Chong Kun Dang topped in H1 clinical trial by Nam Doo-hyun 2018-06-21 11:11
BMS Korea: Baraclude combo therapy shows promise for cure by Marian Chu 2018-06-20 17:16
Why was Il-yang out from innovative pharmaceutical firms list? by So Jae-hyeon 2018-06-20 17:13
GC, Yuhan to cooperate for drug development by Lee Han-soo 2018-06-19 16:07
라인
Safety of heat-not-burn tobacco still controversial by Lee Hye-seon 2018-06-19 15:41
Dong-A ST’s toenail fungal treatment leads local market by Lee Han-soo 2018-06-19 15:07
EU approves Daewoong’s Nabota plant by Lee Han-soo 2018-06-19 11:43
‘Medytox botulinum toxin worth 600 billion won in China’ by Nam Doo-hyun 2018-06-19 09:26
Companies enter pharma biz through equity investment, acquisition by So Jae-hyeon 2018-06-18 16:13
라인
BMS Korea presents trial results for Baraclude by Marian Chu 2018-06-18 11:46
Will SGLT-2 inhibitors win more antidiabetic prescriptions? by Nam Doo-hyun 2018-06-15 11:58
Huons to export BTX to Brazil, Iran by Lee Han-soo 2018-06-14 16:15
Highlights of US cancer meet: immunotherapy, gastrointestinal cancer by Nam Doo-hyun 2018-06-14 15:51
Samsung Bioepis to promote rheumatism treatments in Europe by So Jae-hyeon 2018-06-14 14:59
여백
여백
여백
Back to Top